Literature DB >> 8064070

Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire.

J Bousquet1, M Bullinger, C Fayol, P Marquis, B Valentin, B Burtin.   

Abstract

BACKGROUND AND AIM: Perennial allergic rhinitis may impair social life. General scales of quality of life (QOL) are used to detect the importance of social life impairment, but the reliability and validity of QOL measures should be tested in patients with perennial allergic rhinitis. The extent to which QOL scores differ in patients with rhinitis and healthy subjects is unknown.
METHODS: A cross-sectional study was carried out in 111 patients with moderate to severe perennial allergic rhinitis and 116 healthy subjects to assess the validity of a general QOL scale, the SF-36 Health Status Questionnaire. This scale is based on 36 items selected to represent nine health concepts (dimensions). The internal reliability of each dimension of the questionnaire was examined. The differences in QOL scores between patients with rhinitis and healthy subjects were studied.
RESULTS: Most QOL scores were highly reliable. There was a significant impairment in eight of nine QOL dimensions in patients with perennial allergic rhinitis in comparison with healthy subjects.
CONCLUSIONS: The SF-36 Health Status Questionnaire allows discrimination between patients with perennial allergic rhinitis and healthy subjects.

Entities:  

Mesh:

Year:  1994        PMID: 8064070     DOI: 10.1016/0091-6749(94)90038-8

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  57 in total

Review 1.  Intranasal corticosteroids for allergic rhinitis: superior relief?

Authors:  L P Nielsen; N Mygind; R Dahl
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Treating seasonal allergic rhinitis. Well designed experiments should have been used.

Authors:  Sam Shuster
Journal:  BMJ       Date:  2002-05-25

3.  Quality-of-life outcomes and the use of antihistamines in a French national population-based sample of patients with perennial rhinitis.

Authors:  P D Pariente; C LePen; F Los; J Bousquet
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

4.  Quality of life in adolescents with mild asthma.

Authors:  Teal S Hallstrand; J Randall Curtis; Moira L Aitken; Sean D Sullivan
Journal:  Pediatr Pulmonol       Date:  2003-12

5.  Qualitative Development of the Rhinitis Control Assessment Test (RCAT), an Instrument for Evaluating Rhinitis Symptom Control.

Authors:  Robert A Nathan; Anand A Dalal; Richard H Stanford; Eli O Meltzer; Michael Schatz; Jennifer Derebery; Matthew Mintz; Michelle A Thompson; Dana B Dibenedetti
Journal:  Patient       Date:  2010-06-01       Impact factor: 3.883

6.  Assessment of Duodopa® effects on quality of life of patients with advanced Parkinson's disease and their caregivers.

Authors:  Rosella Ciurleo; Francesco Corallo; Lilla Bonanno; Viviana Lo Buono; Giuseppe Di Lorenzo; Roberta Versaci; Cettina Allone; Rosanna Palmeri; Placido Bramanti; Silvia Marino
Journal:  J Neurol       Date:  2018-06-27       Impact factor: 4.849

7.  The Effect of Religious Intervention Using Prayer for Quality of Life and Psychological Status of Patients with Permanent Pacemaker.

Authors:  Ebrahim Naimi; Owrang Eilami; Amin Babuei; Karim Rezaei; Moslem Moslemirad
Journal:  J Relig Health       Date:  2020-04

8.  Does allergic rhinitis affect communication skills in young adults?

Authors:  Can Cemal Cingi; Öner Sakallıoğlu; Nuray Bayar Muluk; Cemal Cingi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-03       Impact factor: 2.503

9.  Impact of allergic rhinitis on quality of life in patients with bronchial asthma.

Authors:  Maha M Elkholy; Mahmoud Hassan Khedr; Ashraf Halawa; Ayman Elbaramawy
Journal:  Int J Health Sci (Qassim)       Date:  2012-06

Review 10.  Impact of sleep as a specific marker of quality of life in allergic rhinitis.

Authors:  Vanesa González-Núñez; Antonio Luís Valero; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.